## Sputum Conversion Target Under NTEP **Key Point:** According to NTEP (National Tuberculosis Elimination Program) guidelines, the sputum conversion target at the end of 2 months of anti-TB therapy in a well-functioning TB unit is **≥75%** of newly diagnosed sputum-positive pulmonary TB cases. ### Why 2-Month Sputum Conversion Matters 1. **Infectivity reduction:** Sputum conversion indicates bacillary clearance and reduced transmission risk to contacts. 2. **Treatment efficacy marker:** Failure to convert sputum by 2 months raises suspicion for drug resistance or non-adherence. 3. **Program quality indicator:** Sputum conversion rates reflect the effectiveness of case management and drug quality in a TB unit. ### NTEP Performance Benchmarks - **≥75% sputum conversion at 2 months** is the standard benchmark for a well-functioning TB unit under NTEP/RNTCP guidelines (Park's Textbook of Preventive and Social Medicine, 26th edition). - **≥85%** is sometimes cited in older RNTCP literature as an aspirational target but is NOT the standard benchmark used for program evaluation. - **≥90% treatment success rate** is the overall treatment outcome target under NTEP. ### Clinical Pearl - Patients who do not convert sputum by 2 months require investigation for: - Drug-resistant TB (MDR-TB, XDR-TB) - Poor adherence to therapy - Malabsorption or drug interactions - Immunosuppression (HIV co-infection) **High-Yield:** The ≥75% sputum conversion rate at 2 months is the key performance indicator used to evaluate TB program performance and identify units requiring intervention under NTEP guidelines. [cite: Park's Textbook of Preventive and Social Medicine, 26th edition, Chapter on National Health Programs — TB Control]
Sign up free to access AI-powered MCQ practice with detailed explanations and adaptive learning.